Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
0.990
+0.103 (11.56%)
Nov 21, 2024, 4:00 PM EST - Market closed
Verrica Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 45 | 308 | 113 | 252 | 298 | 410 | |
| Market Cap Growth | -62.05% | 172.47% | -55.17% | -15.33% | -27.31% | 95.57% | |
| Enterprise Value | 69 | 267 | 75 | 216 | 263 | 339 | |
| Last Close Price | 0.99 | 7.32 | 2.75 | 9.16 | 11.51 | 15.89 | |
| PS Ratio | 5.00 | 60.09 | 12.51 | 21.01 | - | - | |
| PB Ratio | -1.82 | 15.58 | 2.82 | 7.73 | 9.03 | 6.30 | |
| P/TBV Ratio | - | 15.58 | 2.82 | 7.73 | 9.03 | 6.30 | |
| EV/Sales Ratio | 7.52 | 52.19 | 8.32 | 17.98 | - | - | |
| Debt / Equity Ratio | -1.38 | 2.30 | 0.04 | 1.33 | 1.13 | 0.00 | |
| Asset Turnover | 0.14 | 0.08 | 0.14 | 0.16 | - | - | |
| Quick Ratio | 1.10 | 4.34 | 10.05 | 1.53 | 1.66 | 18.51 | |
| Current Ratio | 1.34 | 4.55 | 11.31 | 1.61 | 1.71 | 19.39 | |
| Return on Equity (ROE) | -2059.89% | -224.08% | -67.42% | -106.97% | -87.13% | -36.53% | |
| Return on Assets (ROA) | -71.41% | -62.56% | -21.32% | -25.04% | -35.23% | -23.45% | |
| Return on Capital (ROIC) | -93.65% | -73.97% | -22.64% | -26.42% | -37.10% | -24.32% | |
| Earnings Yield | -188.26% | -21.76% | -21.67% | -13.92% | -14.34% | -6.89% | |
| FCF Yield | -132.07% | -12.65% | -16.77% | -11.29% | -10.64% | -6.86% | |
| Buyback Yield / Dilution | -5.62% | -32.72% | -26.32% | -8.20% | -0.39% | -69.80% | |
| Total Shareholder Return | -5.62% | -32.72% | -26.32% | -8.20% | -0.39% | -69.80% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.